Low-dose oral minoxidil, the hair growth drug which is the active ingredient in Rogaine, may be safe and effective for ...

One in eight women will suffer from breast cancer in their lifetime. Eight percent will decline treatment due to the fear of alopecia.These statistics from the American Cancer Society and a 2021 study ...

All of the women who took low-dose minoxidil experienced either hair regrowth or a stabilization of their hair loss within three to six months of starting the therapy, researchers found.

Topical ET-02 demonstrated successful results in its first-in-human clinical trial for the treatment of androgenic alopecia, ...

Two of the most well-known topical treatments for men and women are minoxidil and corticosteroids. Both have undergone research studies and have shown promising results to help combat certain ...

In a 2015 study, participants with androgenetic alopecia used either topical minoxidil or rosemary oil on their scalp. When researchers examined their hair at a three-month and six-month follow-up ...

Eirion Therapeutics Inc., a biopharmaceutical company focused on developing innovative aesthetic prescription product offerings, announced today the successful results of its first-in-man clinical ...